Actively Recruiting
Phage Safety Cohort Study
Led by Hospices Civils de Lyon · Updated on 2023-04-13
100
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This cohort study aims to describe the adverse events related to the use of bacteriophages to treat serious infections, data from the literature being almost non-existent on this subject.
CONDITIONS
Official Title
Phage Safety Cohort Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient 18 years of age or older with a serious infection treated at CRIOAc Lyon by phage therapy
- Patient who did not object to participating in the study
- Patients having a minimum weight of 46 kg
You will not qualify if you...
- Patients under guardianship or curatorship
- Patients deprived of liberty
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospices Civils de Lyon
Lyon, France, 69004
Actively Recruiting
Research Team
J
Johanna Boulant, CRA
CONTACT
T
Tristan Ferry, Md,PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here